• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing

Are Pandemic-Driven Panic Buying Stocks Suddenly Passe?

There is a lingering apprehension that the moment has passed for many of these names.
By KEVIN CURRAN Nov 05, 2021 | 01:30 PM EDT
Stocks quotes in this article: PG, KMB, UL, JNJ, CLX, CHWY, ROKU, TSLA

During the opening stages of the coronavirus pandemic, there were few better stocks to be holding than consumer staples.

Indeed, as there were empty shelves of toilet paper, stores selling out of sanitizer, and cleared out isles of cleaning products began to populate the internet, stocks like Procter & Gamble (PG) , Kimberly-Clark (KMB) , Unilever (UL) , Johnson & Johnson (JNJ) , and Clorox (CLX) all soared. Similarly, as worries over new variants rippled through to consumers, many of these same stocks saw yet another boost.

However, even as earnings results continue to prove positive, there is a lingering apprehension that the moment has passed for many of these pandemic-driven stock picks.

"Although we believe [Clorox] should ultimately be a long-term beneficiary of consumer habits developed during the pandemic," said JP Morgan analyst Andrea Teixeira in a recent note downgrading the stock. "We think the 2022 outlook highlights that consumer demand has normalized quicker than initially expected."

As an illustration of the impact, Clorox's stock rose about 50% in just the first few months of the pandemic, a stunning rate for a traditionally slow and steady dividend stock. However, from these highs the stock has slumped over 20% to its present state.

Moving beyond Clorox, Teixeira's criticism is salient for many of its peers, as a return to normalcy means a return to normal consumer habits that likely include a great deal less spent on toilet paper, cleaning wipes, and hand sanitizer. The question is one of whether investor tastes should change alongside them.

Cleaning Up Your Portfolio

In line with Teixeira's note on overly optimistic outlooks for consumer staples stocks after the pandemic-driven pop, many investors are advising avoidance of the sector at this point.

"We recommend minimizing exposure to the Consumer Staples companies that benefited from "panic buying" trends created by the COVID-19 pandemic," Brad Gregory, Portfolio Manager and Research Analyst at Buckingham Advisors, told Real Money. "Although panic buying could result in another near-term jump in sales, it would be more reflective of sales being pulled forward rather than a change in underlying demand."

He added that the impacts of inflation that are now rippling through numerous industries are likely to hinder growth in coming quarters. In line with inflationary trends, higher input costs, wages, and transportation costs are likely to put pressure on already modest margins and impact upcoming earnings results.

In that sense, investors approaching the sector now are doomed to be disappointed. At the very least, the entry point at the present moment appears less than ideal.

A Clean Cushion

That said, for those now holding the aforementioned stocks or those taking a more long-term view of the consumer staples sector, there is reason to remain optimistic.

In terms of valuations, the sector is not exorbitantly priced at the moment. As high profile, trend-driven stocks like Chewy (CHWY) , Roku (ROKU) , and Tesla (TSLA) tout price to earnings ratios in the triple digits, if not quadruple, consumer staple stocks provide a good margin of safety. In fact, many of the stocks within the sector are trading at multiples essentially in line with the overall S&P PE ratio.

It is also worth noting that in terms of this safety, many of these stocks provide a strong and stable income stream via their time-tested dividends. For example, Clorox, Johnson & Johnson, and Procter & Gamble all carry dividend yields north of 2%, while both Unilever and Kimberly Clark hover closer toward a 4% yield. Importantly, each of the dividends appear eminently safe, with raises in the yield dating back decades and now buttressed by strong balance sheets.

"I don't believe that long-term investors will be disappointed by buying and holding firms like Procter & Gamble, Clorox, Johnson & Johnson and many other firms that have stood the test of time and have been able to consistently increase earnings and dividends," Robert Johnson, Professor of Finance at Creighton University said. "It is always a good time to buy firms with strong balance sheets, earnings power, and a history of increasing dividends."

As such, if one is not timing their entry too carefully and is more comfortable with steady income rather than rapid growth, the sector could still be quite attractive. It is just important not to expect share prices to approach their pandemic-driven heights anytime in the immediate future.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Kevin Curran was Long PG.

TAGS: Investing | Markets | Stocks | Trading | Consumer | Consumer Staples | Consumer Products | Coronavirus

More from Investing

More Good Dividend Stocks With Pretty Charts

Bruce Kamich
Jan 27, 2023 1:31 PM EST

In this second part of a two-part series, we look at the final five of 10 stocks with the best of the both worlds.

Even Some Out of Fashion Names Are Now Back in Style

Jonathan Heller
Jan 27, 2023 12:30 PM EST

Sure, we're only one month in to 2023, but so far these stocks are starting the new year with a bang.

I'm Making Small Bets With These 2 Stocks

Bret Jensen
Jan 27, 2023 11:30 AM EST

While I remain cautious on the overall market, I continue to act upon the limited opportunities I'm finding in the current market.

Chevron Is Crushing It and for My Portfolio Too: Here's the Trade

Stephen Guilfoyle
Jan 27, 2023 10:51 AM EST

The only reason to exit the stock now is profit-taking.

Good Dividend Payers With Pretty Charts

Bruce Kamich
Jan 27, 2023 10:15 AM EST

You can have the best of both worlds -- at least when it comes to a select group of dividend stocks -- as we'll see in this first part of a two part series.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:48 AM EST REAL MONEY

    Watch Doug Kass on the Daily Rundown!

    In today's Action Alerts PLUS Daily Rundown, Doug ...
  • 11:03 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend On Real Money

    It's time to start using this power to build great...
  • 03:06 PM EST BOB LANG

    LEAPS Webinar

    This week, I offered a free webinar session talkin...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login